| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NM1111-1325 |
| P953 | full work available at URL | http://www.nature.com/articles/nm1111-1325 |
| http://www.nature.com/articles/nm1111-1325.pdf | ||
| https://www.nature.com/articles/nm1111-1325.pdf | ||
| P698 | PubMed publication ID | 22064391 |
| P2093 | author name string | Melinda Wenner Moyer | |
| P2860 | cites work | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia | Q29617201 |
| Selective inhibition of BET bromodomains | Q24301009 | ||
| c-Myc regulates transcriptional pause release | Q24629119 | ||
| Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription | Q24672881 | ||
| Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia | Q27674674 | ||
| BET bromodomain inhibition as a therapeutic strategy to target c-Myc | Q28247024 | ||
| Targeting MYC dependence in cancer by inhibiting BET bromodomains | Q29617196 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1325 | |
| P577 | publication date | 2011-11-07 | |
| P1433 | published in | Nature medicine | Q1633234 |
| P1476 | title | First drugs found to inhibit elusive cancer target | |
| P478 | volume | 17 |
| Q42380933 | A fast, open source implementation of adaptive biasing potentials uncovers a ligand design strategy for the chromatin regulator BRD4. |
| Q46924536 | Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma |
| Q33907067 | Chromatin-regulating proteins as targets for cancer therapy |
| Q34100931 | Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1 |
| Q61796439 | Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma |
| Q92276520 | Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers |
| Q92443585 | Nanoparticles Loaded with the BET Inhibitor JQ1 Block the Growth of Triple Negative Breast Cancer Cells In Vitro and In Vivo |
Search more.